SLC25A44 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.757400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.076400E-01
Normal-vs-Stage2
8.900400E-01
Normal-vs-Stage3
8.021900E-02
Normal-vs-Stage4
1.003380E-01
Stage1-vs-Stage2
1.633820E-01
Stage1-vs-Stage3
2.043600E-02
Stage1-vs-Stage4
4.586000E-01
Stage2-vs-Stage3
7.259900E-02
Stage2-vs-Stage4
4.871600E-02
Stage3-vs-Stage4
1.232010E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.861400E-01
Normal-vs-AfricanAmerican
9.495600E-02
Normal-vs-Asian
4.876800E-01
Caucasian-vs-AfricanAmerican
3.957600E-02
Caucasian-vs-Asian
2.912800E-01
AfricanAmerican-vs-Asian
1.883050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.545000E-01
Normal-vs-Female
5.341800E-01
Male-vs-Female
7.525800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.290800E-01
Normal-vs-Age(41-60Yrs)
4.922500E-02
Normal-vs-Age(61-80Yrs)
7.441800E-01
Normal-vs-Age(81-100Yrs)
4.623600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.243200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.497400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.021000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.294100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.702300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.684800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.190410E-01
Normal-vs-Daily Drinker
9.405500E-02
Normal-vs-Weekly Drinker
1.592450E-01
Normal-vs-Occasional Drinker
2.109800E-01
Normal-vs-Social Drinker
7.593200E-01
Non Drinker-vs-Daily Drinker
7.985800E-01
Non Drinker-vs-Weekly Drinker
2.926000E-02
Non Drinker-vs-Occasional Drinker
3.743900E-02
Non Drinker-vs-Social Drinker
1.265150E-01
Daily Drinker-vs-Weekly Drinker
2.385700E-02
Daily Drinker-vs-Occasional Drinker
2.993600E-02
Daily Drinker-vs-Social Drinker
8.748300E-02
Weekly Drinker-vs-Occasional Drinker
7.971600E-01
Weekly Drinker-vs-Social Drinker
3.792200E-01
Occasional Drinker-vs-Social Drinker
5.347400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.806800E-01
Normal-vs-Grade 2
6.815000E-01
Normal-vs-Grade 3
3.231200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.403200E-01
Grade 1-vs-Grade 3
2.739200E-01
Grade 1-vs-Grade 4
2.806800E-01
Grade 2-vs-Grade 3
4.070400E-01
Grade 2-vs-Grade 4
6.815000E-01
Grade 3-vs-Grade 4
3.231200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.799000E-01
Normal-vs-NonDiabetic
6.165000E-01
Diabetic-vs-NonDiabetic
1.467400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.089600E-01
Normal-vs-NoPancreatitis
9.563800E-01
Pancreatitis-vs-NoPancreatitis
9.042400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.419990E-01
Normal-vs-N1
7.486400E-01
N0-vs-N1
1.003640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.457000E-01
Normal-vs-TP53-NonMutant
4.956000E-01
TP53-Mutant-vs-TP53-NonMutant
1.756170E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
